BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 1998
View Archived Issues
Elevated plasma P-selectin levels are associated with hypercholesterolemia
Read More
Bayer prepares new compounds particularly useful for acute and chronic inflammation
Read More
Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan
Read More
Campath-1H enters pivotal phase III testing stage
Read More
Metabasis Therapeutics and Pfizer extend ARA research collaboration
Read More
FDA approves another new indication for Lovenox
Read More
TNT will assess further benefits of Lipitor
Read More
More protein tyrosine kinase inhibitors in the pipeline at Glaxo Wellcome
Read More
Novel apoptosis-related protease disclosed by Genetics Institute
Read More
Inhibitors of MMP enzymes synthesized at American Cyanamid
Read More
Novel steroids discovered at Inflazyme are particularly useful for asthma
Read More
Interferon-inducing purines disclosed by Japan Energy
Read More
Melacine marketing application granted expedited review by EMEA
Read More
Biomira announces sale of diagnostics to Centocor
Read More
Molecular Biosystems completes phase II trial of Oralex
Read More
Orphan Medical announces results of Busulfex clinical trials
Read More
Targeted Genetics announces collaboration with NHLBI
Read More
Major advance in glaucoma gene research
Read More
Megabios acquires rheumatology patent and technology, updates development program
Read More
BioTransplant and MedImmune announce patent for MEDI-507 and BTI-322 antibodies
Read More
AVI BioPharma and ImmunoTherapy announce preliminary results of phase II vaccine study
Read More
Ligand reports positive results of Panretin phase III trial
Read More
FDA advisory committee will discuss Aggrastat NDA later this week
Read More
Phase Ib results reported for allosteric Hb modifier RSR13
Read More
Early clinical trial evaluates orbofiban pharmacodynamics
Read More
First clinical trials performed with BMS-181885
Read More
HMR files for European, American approval of arthritis drug
Read More
Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials
Read More
Merck & Co. designates thrombin inhibitor for clinical development
Read More
RPR-130737, a potent nonpeptidyl inhibitor of factor Xa
Read More
